These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37172813)

  • 1. Long COVID in Children and Young after Infection or Reinfection with the Omicron Variant: A Prospective Observational Study.
    Pinto Pereira SM; Mensah A; Nugawela MD; Stephenson T; Ladhani SN; Dalrymple E; Dudley J; McOwat K; Simmons R; Heyman I; Segal T; Semple MG; Xu L; ; Shafran R
    J Pediatr; 2023 Aug; 259():113463. PubMed ID: 37172813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Covid-19 condition (Long Covid) in children and young people 12 months after infection or reinfection with the Omicron variant: a prospective observational study.
    Pinto Pereira SM; Nugawela MD; Stephenson T; Foret-Bruno P; Dalrymple E; Xu L; Whittaker E; Heyman I; Ford T; Segal T; Chalder T; Ladhani SN; Mensah AA; McOwat K; Simmons R; ; Shafran R
    Sci Rep; 2024 Apr; 14(1):9957. PubMed ID: 38693285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 5. Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents.
    Ertesvåg NU; Iversen A; Blomberg B; Özgümüş T; Rijal P; Fjelltveit EB; Cox RJ; Langeland N;
    EBioMedicine; 2023 Jun; 92():104599. PubMed ID: 37149931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
    Stich M; Benning L; Speer C; Garbade SF; Bartenschlager M; Kim H; Jeltsch K; Tabatabai J; Niesert M; Janda A; Renk H; Elling R; Hoffmann GF; Kräusslich HG; Müller B; Bartenschlager R; Tönshoff B
    J Med Virol; 2023 Mar; 95(3):e28582. PubMed ID: 36794653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower prevalence of post-Covid-19 Condition following Omicron SARS-CoV-2 infection.
    de Bruijn S; van Hoek AJ; Mutubuki EN; Knoop H; Slootweg J; Tulen AD; Franz E; van den Wijngaard CC; van der Maaden T
    Heliyon; 2024 Apr; 10(7):e28941. PubMed ID: 38617937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants.
    Özüdoğru O; Bahçe YG; Acer Ö
    Ir J Med Sci; 2023 Apr; 192(2):751-756. PubMed ID: 35711013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).
    Foret-Bruno P; Shafran R; Stephenson T; Nugawela MD; Chan D; Ladhani S; McOwat K; Mensah A; Simmons R; Fox Smith L; D'oelsnitz A; Xu L; Dalrymple E; Heyman I; Ford T; Segal T; Chalder T; Rojas N; Pinto Pereira SM;
    Brain Behav Immun; 2024 Jul; 119():989-994. PubMed ID: 38735404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic.
    Boufidou F; Medić S; Lampropoulou V; Siafakas N; Tsakris A; Anastassopoulou C
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Rise in SARS-CoV-2 Reinfection Rate in Vaccinated Hospital Workers during the Omicron Wave: A Prospective Cohort Study.
    Ochoa-Hein E; Leal-Morán PE; Nava-Guzmán KA; Vargas-Fernández AT; Vargas-Fernández JF; Díaz-Rodríguez F; Rayas-Bernal JA; González-González R; Vázquez-González P; Huertas-Jiménez MA; Rajme-López S; Ramos-Cervantes P; Ibarra-González V; García-Andrade LA; Ledesma-Barrientos F; Ponce-de-León A; Sifuentes-Osornio J; Galindo-Fraga A
    Rev Invest Clin; 2022; 74(4):175-180. PubMed ID: 36087938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Reinfection and Severity of the Disease: A Systematic Review and Meta-Analysis.
    Nguyen NN; Nguyen YN; Hoang VT; Million M; Gautret P
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID Syndrome: The Stranger Ghost of Culprit COVID-19.
    Bhandari S; Rankawat G; Joshi S; Tiwaskar M; Lohmror A; Bhandari S
    J Assoc Physicians India; 2023 Feb; 71(2):11-12. PubMed ID: 37354471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of SARS-CoV-2 reinfection by vaccination status, predominant variant and time from prior infection: a cohort study, Reggio Emilia province, Italy, February 2020 to February 2022.
    Vicentini M; Venturelli F; Mancuso P; Bisaccia E; Zerbini A; Massari M; Cossarizza A; De Biasi S; Pezzotti P; Bedeschi E; Giorgi Rossi P; ;
    Euro Surveill; 2023 Mar; 28(13):. PubMed ID: 36995374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.
    Arabi M; Al-Najjar Y; Sharma O; Kamal I; Javed A; Gohil HS; Paul P; Al-Khalifa AM; Laws S; Zakaria D
    BMC Infect Dis; 2023 Jun; 23(1):432. PubMed ID: 37365490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China.
    Shen N; Wu YF; Chen YW; Fang XY; Zhou M; Wang WY; Tang MY; Pan QH; Ma J; Zhang H; Cao Q
    World J Pediatr; 2023 Jan; 19(1):87-95. PubMed ID: 36251118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection Against the Omicron Variant Offered by Previous Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Retrospective Cohort Study.
    Rothberg MB; Kim P; Shrestha NK; Kojima L; Tereshchenko LG
    Clin Infect Dis; 2023 Feb; 76(3):e142-e147. PubMed ID: 35867678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.